Navigation Links
New Insight Into Most Common Forebrain Malformation
Date:8/11/2008

St. Jude researchers identify a molecular mechanism underlying a genetic brain malformation called holoprosencephaly

MEMPHIS, Tenn., Aug. 11 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital scientists have identified one of the molecular mechanisms underlying the genetic brain malformation called holoprosencephaly (HPE). The findings not only yield insights into the most common developmental malformation of the anterior brain and face in newborns, but also help in understanding the intricate process by which the brain forms in the developing fetus.

Led by St. Jude geneticist Guillermo Oliver, Ph.D., the researchers published their findings in the August 11, 2008, issue of the journal Developmental Cell.

"These findings are important, because, while genes that cause HPE have been identified, the interactions among those that produce HPE are not only complex, but poorly understood," Oliver said. "This represents a first step in understanding the mechanism of that interaction."

HPE occurs in about one in every 250 fetuses, frequently causing miscarriage or stillbirth. HPE is present in varying degrees in one in every 16,000 newborns. The disorder is characterized by a failure of the developing brain to separate into right and left hemispheres. Besides brain abnormalities, HPE is characterized by facial malformations such as cleft lip and cleft palate. HPE has been traced to mutations in any of nine genes, although researchers believe the disorder is also influenced by environmental factors such as maternal diabetes, infections during pregnancy or drugs.

In their studies, the researchers sought to understand the role in HPE of a gene that codes for a protein called Six3. In previous studies, Oliver and his colleagues had identified the Six3 protein as critical to fetal brain formation. Also, other studies had implicated defect-causing mutations in Six3 as involved in causing HPE, but they did not know the molecul
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. New insights into common knee injuries
3. SIV infection of natural hosts provides new insights into HIV disease complexity
4. Insight into the struggles of children with language impairments
5. Mothers Blood Could Offer Insights Into Fetal Health
6. Study Offers Insights Into Sensory Perceptions
7. Uncover Key Competitive Intelligence Insights in Webinars Hosted by Best Practices
8. Studies lend insights into colorectal cancer screening
9. Seven Finalists Announced for 2007 Insight Award for Customer Advocacy in Healthcare
10. Influenza: Insights into cell specificity of human vs. avian viruses
11. Genetic approach provides new insight into trastuzumab resistance in breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Thermage Announces Fourth Quarter and Full Year 2007 Financial Results 2Health News:Thermage Announces Fourth Quarter and Full Year 2007 Financial Results 3Health News:Thermage Announces Fourth Quarter and Full Year 2007 Financial Results 4Health News:Thermage Announces Fourth Quarter and Full Year 2007 Financial Results 5Health News:Thermage Announces Fourth Quarter and Full Year 2007 Financial Results 6Health News:Thermage Announces Fourth Quarter and Full Year 2007 Financial Results 7Health News:Thermage Announces Fourth Quarter and Full Year 2007 Financial Results 8Health News:Thermage Announces Fourth Quarter and Full Year 2007 Financial Results 9Health News:Thermage Announces Fourth Quarter and Full Year 2007 Financial Results 10Health News:Eyes a Window to Hearing Loss? 2Health News:Eyes a Window to Hearing Loss? 3Health News:Americans Believe Pettitte had Conversations with Clemens Regarding Both Players' Use of HGH 2Health News:Women who suffered child abuse spend more on health care 2Health News:Women who suffered child abuse spend more on health care 3Health News:Mailman School PH study finds increase in thyroid diseases risk from exposure at Chernobyl 2Health News:Mailman School PH study finds increase in thyroid diseases risk from exposure at Chernobyl 3
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5NMB 26apos 3Bs New Series of Standard Hybrid Stepper Motors Now Available 54875 1NMB 26apos 3Bs New Series of Standard Hybrid Stepper Motors Now Available 54875 2National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 54871 1National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 54871 2National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 54871 3Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 1Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 2Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 3Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 4